1. Stocks
  2. Concord Biotech Ltd.
  3. Swot
swot-logo

Concord Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Concord Biotech Ltd. has 18 Strengths, 7 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Stock passes majority of CANSLIM Investment criteria

Consistent Highest Return Stocks over Five Years

Companies with high TTM EPS Growth

Expensive Performers (DVM)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Top Gainers

Volume Shockers

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

US FDA Warning Letter

Rising Delivery Percentage Compared to Prev Day

Expensive Performers (DVM)